ISRG, has launched its Da Vinci 5 robotic system, adding new workflow and data capabilities to the operating room. The company is integrating artificial intelligence across its platforms to support ...
The stock has averaged annual gains of nearly 25% over the past decade.
THOMASVILLE — Archbold Pulmonology offers patients state-of-the-art technology with the Intuitive Ion robotic bronchoscopy ...
Intuitive Surgical (NasdaqGS:ISRG) reported 19% year-over-year revenue growth in fiscal 2025 Q4. Growth was driven by higher procedure volumes and increased placements of da Vinci robotic systems. The ...
SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...
Hosted on MSN
This often-overlooked growth stock just reported an amazing quarter. Time to buy shares?
The surgical robotics company's procedure growth remained impressive, supporting recurring revenue. Intuitive Surgical's Da Vinci 5 adoption is ramping quickly. Sales of Ion are growing faster than ...
Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...
Intuitive Surgical's share price surged after the company reported 25% YoY revenue growth in the fourth quarter. Despite macro headwinds, robust procedure volumes, international expansion and new ...
On Tuesday, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results